A randomized, double-blind study examining the comparative efficacies and safety
of inhaled epinephrine and nasal decongestant in hospitalized infants with acute
bronchiolitis.
Author(s): Livni G, Rachmel A, Marom D, Yaari A, Tirosh N, Ashkenazi S.
Affiliation(s): Department of Pediatrics A, Schneider Children's Medical Center, Petach Tikva
49202, Israel.
Publication date & source: 2010, Pediatr Infect Dis J. , 29(1):71-3
Optimal treatment of acute bronchiolitis is currently unclear. In a double-blind
study, we found no significant differences between inhaled epinephrine and nasal
decongestant in hospitalized infants with acute bronchiolitis regarding length of
hospitalization, need for oxygen supplementation, or intravenous fluids and
clinical score. Nasal decongestant is as effective as inhaled epinephrine in
acute bronchiolitis.
|